SecBot SecBot
EFFECT ·Filed Jun 29, 2026

NNVC

NANOVIRICIDES, INC.
BEARISH
Impact 5/10
Horizonweeks Processed4mo ago SEC9999999995-26-002136
IPO/offering going effective
Actionable Insight ▼ Bearish

Monitor for any shelf takedown announcement or warrant exercises. The effective shelf creates persistent overhang; a secondary offering could be near-term given the company's cash needs. Watch for pricing of any offering and potential impact on share price.

DirectionBearish
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
NNVC ▲ +10.22% at T+60d
SHORT call ✗ call lost -10.22% · α vs SPY -6.60% · entry $1.37 → $1.51
Entry = T+0 close
Jun 29, 2026
via day close
T+1d
+0.73%
call -0.73% · α +0.05%
$1.38
settled 4mo ago
T+5d
+9.49%
call -9.49% · α -8.10%
$1.50
settled 4mo ago
T+20d
+8.03%
call -8.03% · α -8.31%
$1.48
settled 3mo ago
T+60d
+10.22%
call -10.22% · α -6.60%
$1.51
settled 5w ago

Price Chart

Loading chart...

Executive Summary

NanoViricides' Form S-3 shelf registration became effective on June 26, 2026, allowing the company to offer up to $50 million in securities. Combined with a separate S-3 effective for resale of 1.33 million shares by a selling stockholder, this significantly increases potential dilution risk for existing shareholders, especially given the company's going-concern status and negligible revenue.

Key Facts

  • Effectiveness date: June 26, 2026
  • Shelf registration for up to $50 million in securities (File No. 333-296790)
  • Second S-3 registers 1,333,334 shares for resale by Orca Capital AG upon warrant exercise at $1.75/share (currently out of the money)
  • Market cap ~$31M; company has no revenue and auditor going-concern qualification

Financial Impact

Potential dilution up to ~161% of current market cap if full $50M shelf is utilized; immediate resale overhang from 1.33M shares (~6.5% of outstanding at $1.75 exercise price)

dilutionshare countmarket cap

Risk Factors

  • Dilution from future offerings under the shelf
  • Warrant exercise at below-market price if stock rises above $1.75
  • Going-concern risk increases urgency to raise capital

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-002136
Document: 9999999995-26-002136-index.html9999999995-26-002136
Document: 9999999995-26-002136.txt9999999995-26-002136
9 reports for NNVC
Performance horizon
100% Hit rate @ T+60 3 of 3 directional calls Went positive at some point 3 of 3 best @ T+60▲ +18.18%Jun 5, 2026
Filters
Rows
Reports for NNVC — sortable, filterable
TypeNow
Oct 21, 2026
6d ago
424B5
NEUTRAL ★ 3/10
$1.51awaiting T+60—$1.46 (−3.31%)
Oct 8, 2026
19d ago
DEF 14A
NEUTRAL ★ 3/10
$1.31awaiting T+60—$1.46 (+11.45%)
Jul 27, 2026
13w ago
424B5
BEARISH ★ 6/10
$1.54 $1.48▲ +3.90%▲ +7.95%$1.46 (+5.19%)
Jul 27, 2026
13w ago
424B5
NEUTRAL ★ 4/10
$1.54 $1.48▼ −3.90%▼ −7.95%$1.46 (−5.19%)
Jun 29, 2026
17w ago
EFFECT
BEARISH ★ 5/10
$1.37 $1.51▼ −10.22%▼ −6.60%$1.46 (−6.57%)
Jun 16, 2026
19w ago
EFFECT
NEUTRAL ★ 3/10
$1.36 $1.02▼ −25.00%▼ −26.86%$1.46 (+7.35%)
Jun 15, 2026
19w ago
S-3
NEUTRAL ★ 3/10
$1.36 $1.02▼ −25.00%▼ −26.86%$1.46 (+7.35%)
Jun 5, 2026
20w ago
S-3
BEARISH ★ 6/10
$1.43 $1.17▲ +18.18%▲ +21.69%$1.46 (−2.10%)
May 18, 2026
23w ago
424B5
BEARISH ★ 6/10
$1.51 $1.37▲ +9.27%▲ +14.12%$1.46 (+3.31%)
Showing 9 of 9

US Market Status

Market Open — Closes in 1h 56m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 29, 2026